Previous Close | 60.12 |
1-Year Change | 4.76% |
6-Months Change | -6.91% |
3-Months Change | -3.33% |
Moving Avg (50d) | 59.299 |
Moving Avg (200d) | 61.849 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.14B |
Beta (3-Years) | 0.83 |
Revenue Growth (ttm) | 58.75% |
Net Profit Margin (ttm) | 2.98% |
Return On Assets (ttm) | 1.5% |
EPS (ttm) | 0.51 |
PE Ratio (ttm) | 117.88 |
Dividend Yield | 0.15% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |